Connection

Cameron Wolfe to Tissue Donors

Back to Details
This is a "connection" page, showing publications Cameron Wolfe has written about Tissue Donors.
Cameron Wolfe
Connection Strength
1.020
Tissue Donors
  1. Donor-derived hepatitis C in the era of increasing intravenous drug use: A report of the Disease Transmission Advisory Committee. Clin Transplant. 2018 10; 32(10):e13370.
    View in: PubMed
    Score: 0.369
  2. Buyer beware: The risks of donor-derived vaccine-induced thrombosis and thrombocytopenia. Am J Transplant. 2021 12; 21(12):3829-3830.
    View in: PubMed
    Score: 0.113
  3. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation. Clin Transplant. 2019 03; 33(3):e13476.
    View in: PubMed
    Score: 0.095
  4. Decline of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation. J Am Coll Cardiol. 2018 11 06; 72(19):2408-2409.
    View in: PubMed
    Score: 0.093
  5. Maximizing utilization of the donor pool by appropriate classification of hepatitis C antibody-positive donors. Am J Transplant. 2018 10; 18(10):2380-2381.
    View in: PubMed
    Score: 0.092
  6. Donor-derived hepatitis C transmission from NAT negative donors-Still an unexpected event! Am J Transplant. 2017 11; 17(11):2989.
    View in: PubMed
    Score: 0.087
  7. Donor-derived infections in solid organ transplant patients: toward a holistic approach. Curr Opin Infect Dis. 2017 Aug; 30(4):329-339.
    View in: PubMed
    Score: 0.086
  8. The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year. Transplantation. 2017 07; 101(7):1666-1669.
    View in: PubMed
    Score: 0.085
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.